th1dwilne9reaor

27

A focus on migraine, multiple sclerosis and Alzheimer’s disease

The following figures present prevalence data on three neurological conditions across selected
OECD countries. This original data comes from the Global Burden Disease Study 2017.

Appendix

Source: Global Burden of Disease Study 2017, Institute for Health Metrics and Evaluation at the University of Washington.

Figure 5: Prevalence of Alzheimer's disease and other dementias in selected countries

(age standardised, both sexes, 2017)

Canada

0.49%

0.47% US

Chile

Mexico

Norway

0.60%

Israel

0.56%

0.73% Japan

0.73%

South Korea

0.65%

0.65%

0.64%

Australia

0.51%

UK

0.55%

Turkey

Poland

Spain

0.61%

Hungary

Greece

0.60%

Denmark

0.54%

Germany

0.57%

Italy

0.62%

France

0.60%

Czech

Republic

0.64%

0.56%

0.55%

Australia

Canada

Chile

Czech Republic

Denmark

France

Germany

Greece

Hungary

Israel

Italy

Japan

Mexico

Norway

Poland

South Korea

Spain

Turkey

UK

US

242,870

378,348

127,656

142,442

68,488

1,056,963

1,343,357

187,368

140,478

70,595

1,170,816

3,579,156

565,863

65,000

493,359

520,751

756,516

622,457

817,926

2,883,963

Country

Prevalent cases,

all ages